TBT Pharma

TBT Pharma, founded with a mission to revolutionize dermatological treatments, focuses on re-purposing generic and off-patent compounds to address underlying pathologies rather than just symptoms. The company is dedicated to developing and commercializing targeted therapeutic solutions for conditions such as psoriasis, orphan diseases, and other inflammatory skin disorders. By leveraging recent discoveries in skin science, TBT Pharma aims to provide innovative and effective treatments that significantly improve patient outcomes.

Notable figures associated with TBT Pharma include leading dermatologists and researchers who have contributed to its clinical-stage advancements. The startup has garnered attention from key investors in the biotech sector, recognizing its potential to disrupt traditional dermatological treatment paradigms. Among its achievements, TBT Pharma has successfully advanced several compounds into clinical trials, demonstrating promising results. The company's impact lies in its novel approach to treating skin conditions, offering hope to patients with previously limited options.